awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42770955-03AF8AAA-C5D2-4C5E-9125-927A264D52C6
Q42770955-03AF8AAA-C5D2-4C5E-9125-927A264D52C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770955-03AF8AAA-C5D2-4C5E-9125-927A264D52C6
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.
P2860
Q42770955-03AF8AAA-C5D2-4C5E-9125-927A264D52C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770955-03AF8AAA-C5D2-4C5E-9125-927A264D52C6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
830bab48ca3b76986406b17640a40b7d40afa6e9
P2860
Phase I and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors.